LDS/Medical Tests/Cutaneous Anaplastic Large Cell Lymphoma, 6p25.3 (IRF4) Rearrangement, FISH, Tissue

Cutaneous Anaplastic Large Cell Lymphoma, 6p25.3 (IRF4) Rearrangement, FISH, Tissue

Cutaneous anaplastic large cell lymphoma (pcALCL) is a subtype of T-cell non-Hodgkin lymphoma characterized by large, atypical lymphoid cells with strong CD30 expression. The disease manifests predominantly in the skin, often as solitary or localized nodules, papules, or ulcerated lesions on the trunk, extremities, or head and neck. While these lesions may spontaneously regress, relapse is common. Systemic dissemination is rare compared with systemic ALCL.

The IRF4 (Interferon Regulatory Factor 4, also known as MUM1) gene rearrangement on chromosome 6p25.3 has emerged as a diagnostic marker in pcALCL. IRF4 is a transcription factor important in lymphocyte differentiation, and its rearrangement is highly specific for primary cutaneous ALCL and related CD30-positive lymphoproliferative disorders. Detection of this rearrangement by fluorescence in-situ hybridization (FISH) aids in distinguishing pcALCL from other mimickers, including systemic ALK-negative ALCL, lymphomatoid papulosis, and other cutaneous lymphomas.

  • As aid in the diagnosis of cutaneous anaplastic large cell lymphoma
  • Aids in differentiation from other cutaneous lymphoproliferative disorders
  • Provides prognostic information, as pcALCL generally carries a favorable prognosis
  • Therapy monitoring and disease management
A positive result indicates the presence of IRF4 gene rearrangement and confirms the diagnosis or susceptibility to cutaneous anaplastic large cell lymphoma. A negative result indicates the absence of IRF4 gene rearrangement and rules out the cutaneous subtype of anaplastic large cell lymphoma.  

Negative

Fluorescence in-situ hybridization (FISH) using IRF4 break-apart probes.

Formalin-fixed, paraffin-embedded (FFPE) tissue blocks or unstained slides (4–6 µm sections).

Stability fixed tissues are stable at room temperature for long time.

Histopathology with H&E staining, Immunohistochemistry: CD30, ALK, EMA, MUM1/IRF4, T-cell receptor (TCR) gene rearrangement studies, CBC, LDH, flow cytometry for systemic disease evaluation.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login